BRAF V600Q-mutated lung adenocarcinoma with duodenal metastasis and extreme leukocytosis

doi:10.5306/wjco.v8.i4.360

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 8, Issue 4

This Article

(360)

(314)

(0)

(5624)

(9)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

- Full Article with Cover (PDF)
- Full Article (XML)

Case Report

World J Clin Oncol. Aug 10, 2017; 8(4): 360-365
Published online Aug 10, 2017. doi: 10.5306/wjco.v8.i4.360

Full Size Figure Download Figure

Figure 2 Esophagogastroduodenoscopy showing the malignant-appearing 1-cm mass in the second part of the duodenum. The scope could not traverse the lesion and the exam could not be finished. Cold forceps biopsies were taken for histology.

Citation: Qasrawi A, Tolentino A, Abu Ghanimeh M, Abughanimeh O, Albadarin S. BRAF V600Q-mutated lung adenocarcinoma with duodenal metastasis and extreme leukocytosis. World J Clin Oncol 2017; 8(4): 360-365
URL: https://www.wjgnet.com/2218-4333/full/v8/i4/360.htm
DOI: https://dx.doi.org/10.5306/wjco.v8.i4.360

Qasrawi A, Tolentino A, Abu Ghanimeh M, Abughanimeh O, Albadarin S. BRAF V600Q-mutated lung adenocarcinoma with duodenal metastasis and extreme leukocytosis. World J Clin Oncol 2017; 8(4): 360-365 [PMID: 28848703 DOI: 10.5306/wjco.v8.i4.360]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.